Report Code : CVMI2603252601501 | Published Date : March 30, 2025

The global cancer biomarkers market was valued at USD 18.6 billion in 2023 and is projected to reach USD 48.3 billion by 2031, growing at a 12.7% CAGR (ClearView Market Insights, 2024). The adoption of precision oncology, advancements in liquid biopsy, and AI-driven diagnostic platforms fuel this expansion.

2. Technological Breakthroughs (2024)

2.1 Liquid Biopsy Innovations

  • Guardant360® CDx: Detects over 1,000 mutations from 10 mL of blood (FDA-approved).
  • FOUNDATION ONE® Liquid: TMB/MSI profiling with 95% concordance vs tissue.
  • Grail’s Galleri®: Multi-cancer early detection (MCED) for 50+ cancers.

2.2 AI/ML Integration

Platform

Function

Clinical Impact

Paige Prostate

AI pathology (99% sensitivity)

Reduces false negatives by 45%

Tempus xF

Genomic + clinical data fusion

30% faster therapy matching

PathAI’s PD-L1

Automated scoring

Cuts interpretation time by 70%

2.3 Novel Biomarker Classes

  • Exosomal Proteins: Caris Life Sciences’ ExoDx™ predicts therapy resistance.
  • Methylation Signatures: Illumina’s TSO500 detects epigenetic drivers.
  • Circulating Tumor DNA (ctDNA): Natera’s Signatera™ monitors recurrence.

3. Application-Specific Advances

3.1 Solid Tumors (XX% Market Share)

  • NSCLC: Foundation Medicine’s tissue-free TMB validated for Keytruda®.
  • Breast Cancer: Agendia’s MammaPrint® reduces chemo use by 38%.

3.2 Hematologic Malignancies (XX%)

  • CLL: Adaptive’s ClonoSEQ® detects 1-in-1M MRD cells.
  • AML: Invivoscribe’s LymphoTrack® IDs FLT3/IDH2 mutations.

3.3 Early Detection (XX%)

  • Colorectal: Exact Sciences’ Cologuard® adoption hits 45% in Medicare.
  • Pancreatic: Canary Foundation’s Early Test detects Stage I/II at 92% accuracy.

4. Competitive Landscape

Company

Market Share

Flagship Product

2024 Launch

Roche

24%

FoundationOne® Liquid

TMB/MSI + HRD scoring

Guardant Health

19%

Guardant360® CDx

1,000+ mutation panel

Exact Sciences

15%

Cologuard®

Multi-cancer RNA signatures

Natera

12%

Signatera™

ctDNA recurrence monitoring

Emerging Players:

  • Freenome: AI-powered multi-omics early detection.
  • GRAIL: Galleri® MCED expanding to 50 cancers.

5. Regional Adoption

  • North America (XX%): CMS coverage for Guardant360® drives uptake.
  • Europe (32%): ESMO guidelines mandate NGS testing for all NSCLC.
  • Asia-Pacific (XX%): China NMPA fast-tracks 10 liquid biopsy kits.




Reasons To Buy

Image



Scope

Image

Key Players

  • Roche
  • Thermo Fisher Scientific
  • Abbott
  • Bio-Rad Laboratories
  • Qiagen
  • Siemens Healthineers
  • Agilent Technologies

Global Cancer Biomarkers Market Report

  1. 1. Global Cancer Biomarkers Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Global Cancer Biomarkers Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
    2. Global Cancer Biomarkers Market Research Report - Preface
    1. 2.1 Global Cancer Biomarkers Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Type
      2. 2.1.2 By Application
      3. 2.1.3 By Cancer Type
      4. 2.1.4 By End-User
      5. 2.1.5 By Region
    3. Global Cancer Biomarkers Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Type, By Application, By Cancer Type, By End-User, By Country
    3. 3.3. Opportunities – By Type, By Application, By Cancer Type, By End-User, By Country
    4. 3.4. Trends – By Type, By Application, By Cancer Type, By End-User, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Global Cancer Biomarkers Market Research Report – DROTs Impact Analysis
    4. Global Cancer Biomarkers Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. Global Cancer Biomarkers Market, By Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Protein Biomarkers
      1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 5.2 Genetic Biomarkers
      1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 5.3 Metabolic Biomarkers
      1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Global Cancer Biomarkers Market, By Application, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Diagnostics
      1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 6.2 Prognostics
      1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 6.3 Drug Discovery & Development
      1. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Global Cancer Biomarkers Market, By Cancer Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Breast Cancer
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 7.2 Lung Cancer
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 7.3 Colorectal Cancer
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 7.4 Prostate Cancer
      1. 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 7.5 Others
      1. 7.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    8. Global Cancer Biomarkers Market, By End-User, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 Hospitals
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 8.2 Research Laboratories
      1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 8.3 Diagnostic Centers
      1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    9. Global Cancer Biomarkers Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 North America
      1. 9.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 9.2 Europe
      1. 9.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 9.3 Asia-Pacific
      1. 9.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 9.4 Latin America
      1. 9.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 9.5 Middle East & Africa
      1. 9.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 9.6 Global Cancer Biomarkers Market - Opportunity Analysis Index, By Type, By Application, By Cancer Type, By End-User, and Region, 2024 - 2031
    10. North America Cancer Biomarkers Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Protein Biomarkers
      2. 10.1.2 Genetic Biomarkers
      3. 10.1.3 Metabolic Biomarkers
      10.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Diagnostics
      2. 10.2.2 Prognostics
      3. 10.2.3 Drug Discovery & Development
      10.3 By Cancer Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 Breast Cancer
      2. 10.3.2 Lung Cancer
      3. 10.3.3 Colorectal Cancer
      4. 10.3.4 Prostate Cancer
      5. 10.3.5 Others
      10.4 By End-User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.4.1 Hospitals
      2. 10.4.2 Research Laboratories
      3. 10.4.3 Diagnostic Centers
      10.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.5.1 United States
      2. 10.5.2 Canada
      10.6 North America Global Cancer Biomarkers Market – Opportunity Analysis Index, By Type, By Application, By Cancer Type, By End-User, and Country, 2024 - 2031
      10.7 Regional Trends Analysis
      10.8 North America Global Cancer Biomarkers Market Research Report - Company Profiles
      1. 10.8.1 Company 1 (United States)
      2. 10.8.2 Company 2 (Canada)
      3. 10.8.3 Company 3 (Canada)
    11. Europe Global Cancer Biomarkers Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Protein Biomarkers
      2. 11.1.2 Genetic Biomarkers
      3. 11.1.3 Metabolic Biomarkers
      11.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Diagnostics
      2. 11.2.2 Prognostics
      3. 11.2.3 Drug Discovery & Development
      11.3 By Cancer Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Breast Cancer
      2. 11.3.2 Lung Cancer
      3. 11.3.3 Colorectal Cancer
      4. 11.3.4 Prostate Cancer
      5. 11.3.5 Others
      11.4 By End-User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.4.1 Hospitals
      2. 11.4.2 Research Laboratories
      3. 11.4.3 Diagnostic Centers
      11.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.5.1 Germany
      2. 11.5.2 United Kingdom
      3. 11.5.3 France
      4. 11.5.4 Spain
      5. 11.5.5 Italy
      6. 11.5.6 Russia
      7. 11.5.7 Netherlands
      8. 11.5.8 Poland
      9. 11.5.9 Rest of Europe
      11.6 Europe Global Cancer Biomarkers Market – Opportunity Analysis Index, By Type, By Application, By Cancer Type, By End-User, and Country, 2024 - 2031
      11.7 Regional Trends Analysis
      11.8 Europe Global Cancer Biomarkers Market Research Report - Company Profiles
      1. 11.8.1 Company 1 (Germany)
      2. 11.8.2 Company 2 (United Kingdom)
      3. 11.8.3 Company 3 (United Kingdom)
    12. Asia-Pacific Global Cancer Biomarkers Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Protein Biomarkers
      2. 12.1.2 Genetic Biomarkers
      3. 12.1.3 Metabolic Biomarkers
      12.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Diagnostics
      2. 12.2.2 Prognostics
      3. 12.2.3 Drug Discovery & Development
      12.3 By Cancer Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Breast Cancer
      2. 12.3.2 Lung Cancer
      3. 12.3.3 Colorectal Cancer
      4. 12.3.4 Prostate Cancer
      5. 12.3.5 Others
      12.4 By End-User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.4.1 Hospitals
      2. 12.4.2 Research Laboratories
      3. 12.4.3 Diagnostic Centers
      12.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.5.1 China
      2. 12.5.2 Japan
      3. 12.5.3 India
      4. 12.5.4 South Korea
      5. 12.5.5 Australia & NZ
      6. 12.5.6 ASEAN
      7. 12.5.7 Rest of Asia-Pacific
      12.6 Asia-Pacific Global Cancer Biomarkers Market – Opportunity Analysis Index, By Type, By Application, By Cancer Type, By End-User, and Country, 2024 - 2031
      12.7 Regional Trends Analysis
      12.8 Asia-Pacific Global Cancer Biomarkers Market Research Report - Company Profiles
      1. 12.8.1 Company 1 (China)
      2. 12.8.2 Company 2 (Japan)
      3. 12.8.3 Company 3 (Japan)
    13. Latin America Global Cancer Biomarkers Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 13.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.1.1 Protein Biomarkers
      2. 13.1.2 Genetic Biomarkers
      3. 13.1.3 Metabolic Biomarkers
      13.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.2.1 Diagnostics
      2. 13.2.2 Prognostics
      3. 13.2.3 Drug Discovery & Development
      13.3 By Cancer Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.3.1 Breast Cancer
      2. 13.3.2 Lung Cancer
      3. 13.3.3 Colorectal Cancer
      4. 13.3.4 Prostate Cancer
      5. 13.3.5 Others
      13.4 By End-User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.4.1 Hospitals
      2. 13.4.2 Research Laboratories
      3. 13.4.3 Diagnostic Centers
      13.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.5.1 Brazil
      2. 13.5.2 Mexico
      3. 13.5.3 Argentina
      4. 13.5.4 Peru
      5. 13.5.5 Colombia
      6. 13.5.6 Rest of Latin America
      13.6 Latin America Global Cancer Biomarkers Market – Opportunity Analysis Index, By Type, By Application, By Cancer Type, By End-User, and Country, 2024 - 2031
      13.7 Regional Trends Analysis
      13.8 Latin America Global Cancer Biomarkers Market Research Report - Company Profiles
      1. 13.8.1 Company 1 (Brazil)
      2. 13.8.2 Company 2 (Mexico)
      3. 13.8.3 Company 3 (Mexico)
    14. Middle East & Africa Global Cancer Biomarkers Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 14.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.1.1 Protein Biomarkers
      2. 14.1.2 Genetic Biomarkers
      3. 14.1.3 Metabolic Biomarkers
      14.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.2.1 Diagnostics
      2. 14.2.2 Prognostics
      3. 14.2.3 Drug Discovery & Development
      14.3 By Cancer Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.3.1 Breast Cancer
      2. 14.3.2 Lung Cancer
      3. 14.3.3 Colorectal Cancer
      4. 14.3.4 Prostate Cancer
      5. 14.3.5 Others
      14.4 By End-User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.4.1 Hospitals
      2. 14.4.2 Research Laboratories
      3. 14.4.3 Diagnostic Centers
      14.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.5.1 Saudi Arabia
      2. 14.5.2 UAE
      3. 14.5.3 South Africa
      4. 14.5.4 Egypt
      5. 14.5.5 Israel
      6. 14.5.6 Rest of Middle East and Africa
      14.6 Middle East & Africa Global Cancer Biomarkers Market – Opportunity Analysis Index, By Type, By Application, By Cancer Type, By End-User, and Country, 2024 - 2031
      14.7 Regional Trends Analysis
      14.8 Middle East & Africa Global Cancer Biomarkers Market Research Report - Company Profiles
      1. 14.8.1 Company 1 (Saudi Arabia)
      2. 14.8.2 Company 2 (UAE)
      3. 14.8.3 Company 3 (UAE)
    15. Competition Landscape
    1. 15.1 Strategic Dashboard of Top Market Players
      15.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 15.2.1 Roche
      2. 15.2.2 Thermo Fisher Scientific
      3. 15.2.3 Abbott
      4. 15.2.4 Bio-Rad Laboratories
      5. 15.2.5 Qiagen
      6. 15.2.6 Siemens Healthineers
      7. 15.2.7 Agilent Technologies
    16. Data Collection Method and Research Approach
    17. Principal Presumptions and Acronyms



    2.